Randomised controlled trial of intravenous antivenom versus placebo in the treatment of redback spider bite [ 2009 - 2012 ]

Also known as: The redback spider antivenom evaluation II (RAVE-II) study

Research Grant

[Cite as]

Researchers: Prof Geoffrey Isbister (Principal investigator) ,  Prof Simon Brown

Brief description Redback spiderbite is the most common significant envenoming in Australia and bites by the closely related widow spiders are a major global problem. Despite widespread use of redback spider antivenom, no controlled study has tested its effectiveness. This study aims to test the efficacy of antivenom versus placebo in a large multicentre, randomised controlled trial - RAVE-II. It is of critical importance to determine if an expensive treatment with a known risk of allergic reactions is effective.

Funding Amount $AUD 487,440.48

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Viewed: [[ro.stat.viewed]]